InvestorsObserver
×
News Home

Do Analysts Expect Amgen, Inc. (AMGN) Stock to Rise After It Is Down -4.37% in a Month?

Thursday, September 23, 2021 12:54 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Expect Amgen, Inc. (AMGN) Stock to Rise After It Is Down -4.37% in a Month?

Analysts who follow Amgen, Inc. (AMGN) on average expect it to gain 17.63% over the next twelve months. Those same analysts give the stock an average rating of Buy. That average rating earns Amgen, Inc. an Analyst Ranking of 16, which means it ranks higher than 16 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 3.5
Wall Street analysts are rating AMGN a Buy today. Find out what this means to you and get the rest of the rankings on AMGN!

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Amgen, Inc. Stock Today?

Amgen, Inc. (AMGN) stock is trading at $214.57 as of 12:53 PM on Thursday, Sep 23, a rise of $0.93, or 0.44% from the previous closing price of $213.64. The stock has traded between $212.30 and $215.06 so far today. Volume today is below average. So far 889,495 shares have traded compared to average volume of 2,532,279 shares. Click Here to get the full Stock Report for Amgen, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App